Interpreting Multimodal Data Fusion for Glioblastoma Prognosis: A Systematic Literature Review of Explainable AI Applications
A representative clinical scenario involves a 57-year-old patient whose brain MRI reveals an infiltrative mass with central necrosis, with biopsy confirming glioblastoma (GBM, WHO Grade 4). Despite maximal resection, concurrent temozolomide, and radiotherapy, median survival remains 14–16 months, a figure that has rema...